{"count":10,"index":{"built_at":"2026-07-27T07:24:56.692189+00:00","public_records":55311,"revision":"e40e193334293d7287665a7b"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: Cardio Risk Check in the context of Wechseljahre"},"results":[{"answer":"Combining a Cardio Risk Check with menopause context is clinically relevant because estrogen decline during menopause increases cardiovascular risk. Genetic tests can identify variants linked to cholesterol, blood pressure, or inflammation, but effect sizes are small and often not actionable alone. Evidence for genetic-based cardiovascular risk prediction in menopause is moderate at best; traditional risk factors (lipids, blood pressure, lifestyle, family history) and hormonal changes are stronger drivers. MyBody-X may offer a combo test (DNA + biomarkers), but without specific product details, the evidence level is unclear. Caveat: Do not rely solely on genetics. Discuss results with a doctor, especially regarding hormone therapy and lifestyle interventions. The interplay of genes, hormones, and environment is complex.","area":"gesundheit","canonical_id":"gesundheit:canonical-70114c32707d2d1481d600b3","id":"public-f89a9935c9606bf6c44128fc","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Cardio Risk Check in the context of Wechseljahre","score":25.03219872,"snippet":"Combining a Cardio Risk Check with menopause context is clinically relevant because estrogen decline during menopause increases cardiovascular risk. Genetic tests can identify variants linked to cholesterol, blood pressure, or inflammation, but effect sizes are small and often not actionable alone. Evidence for genetic-based cardiovascular risk prediction in menopause is moderate at best; traditional risk factors (lipids, blood pressure, lifestyle, family history) and hormonal changes are stronger drivers. MyBody-X may offer a combo test (DNA + biomarkers), but without specific product details, the evidence level is unclear. Caveat: Do not rely solely on genetics. Discuss results with a doct","sources":[],"title":"Evidence check: Cardio Risk Check in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-f89a9935c9606bf6c44128fc/evidence-check-cardio-risk-check-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The Cardio Risk Check measures standard lipid parameters (total cholesterol, LDL, HDL, triglycerides) and hsCRP as an inflammatory marker. During menopause, cardiovascular risk increases due to estrogen decline, which adversely affects lipid profiles and vascular function. The test can provide risk markers but cannot diagnose heart disease. Evidence is based on clinical practice, not randomized trials. A single test result is of limited value without considering age, blood pressure, smoking, diabetes, and family history. Moreover, this is a blood test, not a genetic test – it cannot identify inherited lipid disorders. For menopausal women, regular risk assessment is advisable, but the test should always be part of a comprehensive medical evaluation. Results can be influenced by acute inflammation, medications, or diet. Using a home test without medical guidance risks misinterpretation or false reassurance. Evidence grade: practice (established clinical markers).","area":"gesundheit","canonical_id":"gesundheit:canonical-b27edf85788d490ab9f8d37b","id":"public-3e042d07958d2bc8771c78d7","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of Wechseljahre","score":24.86996282,"snippet":"The Cardio Risk Check measures standard lipid parameters (total cholesterol, LDL, HDL, triglycerides) and hsCRP as an inflammatory marker. During menopause, cardiovascular risk increases due to estrogen decline, which adversely affects lipid profiles and vascular function. The test can provide risk markers but cannot diagnose heart disease. Evidence is based on clinical practice, not randomized trials. A single test result is of limited value without considering age, blood pressure, smoking, diabetes, and family history. Moreover, this is a blood test, not a genetic test – it cannot identify inherited lipid disorders. For menopausal women, regular risk assessment is advisable, but the test s","sources":[],"title":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-3e042d07958d2bc8771c78d7/evidence-check-cardio-risk-check-herz-kreislauf-risiko-test-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The relationship between Cardio Risk Check and Wechseljahre (menopause) is not directly addressed in the provided knowledge contexts. No specific studies or product descriptions link these two MyBody-X offerings. Generally, cardiovascular risk increases after menopause due to hormonal changes (e.g., declining estrogen). A Cardio Risk Check might be relevant for monitoring lipid profiles or inflammatory markers in menopausal women. However, the provided context lacks evidence for this specific combination. The evidence level is therefore unclear or marketing-based. Consumers should not rely solely on such tests and should consult a healthcare provider for personalized risk assessment.","area":"gesundheit","canonical_id":"gesundheit:canonical-873bedf39fddf32597d11f1f","id":"public-1395bd30c1844423a4c13d13","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"How are Cardio Risk Check and Wechseljahre related?","score":24.75051164,"snippet":"The relationship between Cardio Risk Check and Wechseljahre (menopause) is not directly addressed in the provided knowledge contexts. No specific studies or product descriptions link these two MyBody-X offerings. Generally, cardiovascular risk increases after menopause due to hormonal changes (e.g., declining estrogen). A Cardio Risk Check might be relevant for monitoring lipid profiles or inflammatory markers in menopausal women. However, the provided context lacks evidence for this specific combination. The evidence level is therefore unclear or marketing-based. Consumers should not rely solely on such tests and should consult a healthcare provider for personalized risk assessment.","sources":[],"title":"How are Cardio Risk Check and Wechseljahre related?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-1395bd30c1844423a4c13d13/how-are-cardio-risk-check-and-wechseljahre-related/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Based on the provided context, there is no evidence that a Cardio Risk Check specifically helps during menopause (Wechseljahre). Menopause increases cardiovascular risk due to estrogen decline, but standard clinical assessments (lipid panel, blood pressure, glucose) are well-established. The context mentions hormone tests (batch 2327) and DNA diet tests (batch 638) as marketing-level or unclear evidence, but no direct reference to a Cardio Risk Check product. While monitoring cardiovascular health is important during menopause, the claim that a particular direct-to-consumer test is beneficial lacks support from the given knowledge. Therefore, the evidence is unclear. Caveat: such tests should not replace routine medical care, and results need professional interpretation.","area":"gesundheit","canonical_id":"gesundheit:canonical-16af26fadea434021ac2b14a","id":"public-d1a26719519b44d90394872a","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Can Cardio Risk Check help with Wechseljahre?","score":24.73853611,"snippet":"Based on the provided context, there is no evidence that a Cardio Risk Check specifically helps during menopause (Wechseljahre). Menopause increases cardiovascular risk due to estrogen decline, but standard clinical assessments (lipid panel, blood pressure, glucose) are well-established. The context mentions hormone tests (batch 2327) and DNA diet tests (batch 638) as marketing-level or unclear evidence, but no direct reference to a Cardio Risk Check product. While monitoring cardiovascular health is important during menopause, the claim that a particular direct-to-consumer test is beneficial lacks support from the given knowledge. Therefore, the evidence is unclear. Caveat: such tests shoul","sources":[],"title":"Can Cardio Risk Check help with Wechseljahre?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-d1a26719519b44d90394872a/can-cardio-risk-check-help-with-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The Cardio Risk Check by MyBody-X can provide a rough orientation of cardiovascular risk during menopause, when declining estrogen levels increase heart disease risk. It measures markers like cholesterol (LDL/HDL), triglycerides, blood sugar, and inflammation. However, it is a lifestyle test, not a diagnostic tool. Values fluctuate and require medical interpretation. Do not adjust medication or lifestyle solely based on this test. Evidence: marketing/unclear. Sources: no specific studies in context; product description.","area":"gesundheit","canonical_id":"gesundheit:canonical-b9f3befe093edff5f40c1753","id":"public-6067e3dfbf6fca033668ddbc","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"What role does Cardio Risk Check play in Wechseljahre?","score":24.43761042,"snippet":"The Cardio Risk Check by MyBody-X can provide a rough orientation of cardiovascular risk during menopause, when declining estrogen levels increase heart disease risk. It measures markers like cholesterol (LDL/HDL), triglycerides, blood sugar, and inflammation. However, it is a lifestyle test, not a diagnostic tool. Values fluctuate and require medical interpretation. Do not adjust medication or lifestyle solely based on this test. Evidence: marketing/unclear. Sources: no specific studies in context; product description.","sources":[],"title":"What role does Cardio Risk Check play in Wechseljahre?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-6067e3dfbf6fca033668ddbc/what-role-does-cardio-risk-check-play-in-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The relationship between a Cardio Risk Check (cardiovascular risk test) and menopause (Wechseljahre) is not directly addressed in the provided context. Medically, menopause increases cardiovascular risk due to estrogen decline, affecting blood pressure, lipid profiles, and vascular function. A cardio risk check can be particularly relevant during this phase to identify early risk factors. However, the genetic markers mentioned in the context (e.g., CYP2C9 for warfarin dosing, CYP1A2 for caffeine, MTHFR for homocysteine, ALDH2 for alcohol metabolism, TAS2R38 for bitter taste) have no specific link to menopause. They pertain to other metabolic pathways and are not validated as menopause-specific risk markers. Therefore, the evidence for a direct connection between these particular DNA tests and menopause is unclear. A comprehensive risk assessment should include clinical parameters (blood pressure, lipids, fasting glucose) and lifestyle factors alongside genetic data. Interpretation requires medical guidance, especially during perimenopause.","area":"gesundheit","canonical_id":"gesundheit:canonical-dba57ce588eaf0504e5daffc","id":"public-1cba76d2e734dc592063d703","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"How are Cardio Risk Check | Herz-Kreislauf Risiko-Test and Wechseljahre related?","score":24.36620865,"snippet":"The relationship between a Cardio Risk Check (cardiovascular risk test) and menopause (Wechseljahre) is not directly addressed in the provided context. Medically, menopause increases cardiovascular risk due to estrogen decline, affecting blood pressure, lipid profiles, and vascular function. A cardio risk check can be particularly relevant during this phase to identify early risk factors. However, the genetic markers mentioned in the context (e.g., CYP2C9 for warfarin dosing, CYP1A2 for caffeine, MTHFR for homocysteine, ALDH2 for alcohol metabolism, TAS2R38 for bitter taste) have no specific link to menopause. They pertain to other metabolic pathways and are not validated as menopause-specif","sources":[],"title":"How are Cardio Risk Check | Herz-Kreislauf Risiko-Test and Wechseljahre related?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-1cba76d2e734dc592063d703/how-are-cardio-risk-check-herz-kreislauf-risiko-test-and-wechseljahre-related/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Homocysteine is an amino acid whose elevated blood levels are considered an independent risk factor for cardiovascular disease. During menopause, cardiovascular risk naturally increases due to estrogen decline, and elevated homocysteine may compound this effect. However, the evidence is mixed: some studies show an association between homocysteine and menopause-related vascular changes, but clear clinical intervention data recommending routine measurement or lowering of homocysteine in menopause are lacking. Lowering homocysteine with folic acid, B12, and B6 is possible, but it is not proven to reduce cardiovascular risk. MyBody-X tests can measure homocysteine, but interpretation is limited: single values without considering kidney function, thyroid status, and medications are of little value. Caveat: Do not self-supplement with high-dose B vitamins without medical advice. Evidence: unclear – based on mechanistic and observational data, not on randomized trials in this specific group.","area":"gesundheit","canonical_id":"gesundheit:canonical-733e02be82f5bebe1ae5e12a","id":"public-24dd68f8264badefce31c620","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Homocystein in the context of Wechseljahre","score":24.21470903,"snippet":"Homocysteine is an amino acid whose elevated blood levels are considered an independent risk factor for cardiovascular disease. During menopause, cardiovascular risk naturally increases due to estrogen decline, and elevated homocysteine may compound this effect. However, the evidence is mixed: some studies show an association between homocysteine and menopause-related vascular changes, but clear clinical intervention data recommending routine measurement or lowering of homocysteine in menopause are lacking. Lowering homocysteine with folic acid, B12, and B6 is possible, but it is not proven to reduce cardiovascular risk. MyBody-X tests can measure homocysteine, but interpretation is limited:","sources":[],"title":"Evidence check: Homocystein in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-24dd68f8264badefce31c620/evidence-check-homocystein-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The role of the Cardio Risk Check | Herz-Kreislauf Risiko-Test in menopause cannot be directly determined from the provided context, as neither the test nor menopause is mentioned in the given sources. Generally, cardiovascular risk increases after menopause due to declining estrogen levels. Such a test might theoretically help monitor risk factors like lipids or inflammatory markers. However, this appears to be a commercial test, and its clinical utility in menopause is not supported by strong evidence. Without specific studies or guidelines, its value remains unclear. Women in menopause should not rely solely on such tests but should seek medical advice for comprehensive risk assessment. The evidence grade is 'unclear' or 'marketing' due to lack of valid sources.","area":"gesundheit","canonical_id":"gesundheit:canonical-eca159e96dde8dc626ae916d","id":"public-4fa927815a0c2d3bdf0b09f0","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"What role does Cardio Risk Check | Herz-Kreislauf Risiko-Test play in Wechseljahre?","score":24.08153425,"snippet":"The role of the Cardio Risk Check | Herz-Kreislauf Risiko-Test in menopause cannot be directly determined from the provided context, as neither the test nor menopause is mentioned in the given sources. Generally, cardiovascular risk increases after menopause due to declining estrogen levels. Such a test might theoretically help monitor risk factors like lipids or inflammatory markers. However, this appears to be a commercial test, and its clinical utility in menopause is not supported by strong evidence. Without specific studies or guidelines, its value remains unclear. Women in menopause should not rely solely on such tests but should seek medical advice for comprehensive risk assessment. T","sources":[],"title":"What role does Cardio Risk Check | Herz-Kreislauf Risiko-Test play in Wechseljahre?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-4fa927815a0c2d3bdf0b09f0/what-role-does-cardio-risk-check-herz-kreislauf-risiko-test-play-in-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"An hsCRP level above 3.0 mg/L indicates elevated cardiovascular risk due to systemic inflammation. During menopause (perimenopause and postmenopause), the natural decline in estrogen can increase inflammatory activity and potentially raise hsCRP. However, hsCRP is a non-specific marker: acute infections, injuries, or chronic inflammatory conditions (e.g., rheumatoid arthritis) must be ruled out before interpreting the result. The evidence here is based on clinical practice, not on menopause-specific studies. Lifestyle interventions—such as a balanced diet, regular exercise, and weight management—are the primary strategies to lower elevated hsCRP. A comprehensive cardiovascular risk assessment (including lipid profile, blood pressure, and fasting glucose) is essential. Hormone therapy may affect hsCRP levels but is not recommended solely for cardiovascular prevention. Caveat: repeat testing and clinical context are needed, as hsCRP can fluctuate significantly.","area":"gesundheit","canonical_id":"gesundheit:canonical-13bd117a61e8159f5f9b9aa5","id":"public-d3f2aec9d5b9504e952e7414","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: hsCRP in the context of Wechseljahre","score":24.04455952,"snippet":"An hsCRP level above 3.0 mg/L indicates elevated cardiovascular risk due to systemic inflammation. During menopause (perimenopause and postmenopause), the natural decline in estrogen can increase inflammatory activity and potentially raise hsCRP. However, hsCRP is a non-specific marker: acute infections, injuries, or chronic inflammatory conditions (e.g., rheumatoid arthritis) must be ruled out before interpreting the result. The evidence here is based on clinical practice, not on menopause-specific studies. Lifestyle interventions—such as a balanced diet, regular exercise, and weight management—are the primary strategies to lower elevated hsCRP. A comprehensive cardiovascular risk assessmen","sources":[],"title":"Evidence check: hsCRP in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-d3f2aec9d5b9504e952e7414/evidence-check-hscrp-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Based on the provided context, there is no direct information about a 'Cardio Risk Check' or 'Herz-Kreislauf Risiko-Test' specifically for menopause. Generally, cardiovascular risk increases after menopause due to declining estrogen. Established clinical risk scores (e.g., SCORE2, Framingham) are validated for this period and recommended by guidelines. A consumer test that includes genetic markers (like MTHFR, ALDH2, FTO) or microbiome analysis may offer additional insights, but the evidence for its added value in menopause is limited. Many genetic associations come from GWAS and lack clinical actionability. Polygenic risk scores are less reliable for non-European populations. Therefore, such a test might be used as a supplementary tool, but it should not replace standard medical risk assessment. Caveat: Do not make health decisions based solely on a consumer test; consult a physician for interpretation and follow-up.","area":"gesundheit","canonical_id":"gesundheit:canonical-45110f7524e07c3fb34a7c83","id":"public-e8826844de6a23448ca20ca4","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Is Cardio Risk Check | Herz-Kreislauf Risiko-Test useful for Wechseljahre?","score":23.93326512,"snippet":"Based on the provided context, there is no direct information about a 'Cardio Risk Check' or 'Herz-Kreislauf Risiko-Test' specifically for menopause. Generally, cardiovascular risk increases after menopause due to declining estrogen. Established clinical risk scores (e.g., SCORE2, Framingham) are validated for this period and recommended by guidelines. A consumer test that includes genetic markers (like MTHFR, ALDH2, FTO) or microbiome analysis may offer additional insights, but the evidence for its added value in menopause is limited. Many genetic associations come from GWAS and lack clinical actionability. Polygenic risk scores are less reliable for non-European populations. Therefore, suc","sources":[],"title":"Is Cardio Risk Check | Herz-Kreislauf Risiko-Test useful for Wechseljahre?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-e8826844de6a23448ca20ca4/is-cardio-risk-check-herz-kreislauf-risiko-test-useful-for-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}